OPTHEA LIMITED - Charts / Financials

0.00%

60.0¢

Market Cap $738.7M

Healthcare Biotechnology

Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The... Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The Company has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

MEMPHASYS LIMITED

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.

REFRESH

Day chart unavailable

Day
Open	0.0¢		Day High	0.0¢		Day Low	0.0¢
Daily Volume	0

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
0	0.0¢	0		0	0.0¢	0

Directors & Senior Management

Dr. Megan Baldwin	Founder, Chief Innovation Office
Mr. Tom Reilly	Chief Financial Officer
Dr. Julie Clark	Senior Vice President - Clinical Development
Dr. Dayong Li	Senior Vice President - Biometrics
Dr. Fang Li	Senior Vice President - Regulatory Affairs
Mrs. Karen Adams	Vice President - Finance, Company Secretary
Mr. Anthony Bonifazio	Vice President - Market Access
Dr. John Han	Vice President - Medical Affairs
Mr. Mark O'neill	Vice President - Chemistry, Manufacturing and Controls
Mr. Anand Sundaram	Vice President - Marketing
Dr. Jeremy Max Levin	Non-Executive Independent Chairman of the Board
Ms. Katherine Connell	Non-Executive Director
Mr. Lawrence Gozlan	Non-Executive Independent Director
Mr. Sujal A. Shah	Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 60.0¢		Change 0.000(0.00%)		Mkt cap ! $738.7M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

OPT (ASX) Chart

OPTHEA LIMITED - Charts / Financials

Directors & Senior Management

Top Stories